论文部分内容阅读
目的观察扶正生白颗粒治疗晚期结肠癌化疗所致白细胞减少的临床疗效。方法将60例晚期结肠癌化疗后出现骨髓抑制的患者随机分为两组。治疗组30例给予扶正生白颗粒口服;对照组30例给予利血生、鲨肝醇口服。观察两组外周血白细胞数的变化。结果在2周升白细胞治疗后,治疗组较对照组白细胞计数高,差异有统计学意义(P<0.05)。结论扶正生白颗粒治疗晚期结肠癌化疗后所致白细胞减少,疗效确切,值得临床推广。
Objective To observe the clinical effect of Fuzheng Shengbai Granule in treating leucopenia caused by chemotherapy of advanced colon cancer. Methods Sixty patients with bone marrow suppression after chemotherapy for advanced colon cancer were randomly divided into two groups. 30 cases in the treatment group were given Fuzheng Shengbai Granule orally; in the control group, 30 cases were given reserpine and batylol. The changes of peripheral white blood cells in two groups were observed. Results After 2 weeks of leukocyte treatment, the treatment group had higher leukocyte counts than the control group, with significant difference (P <0.05). Conclusion Fuzheng Shengbai granule treatment of advanced colon cancer caused by leukopenia after chemotherapy, curative effect is exact, worthy of clinical promotion.